MAP PHARMACEUTICALS, INC. Increase (Decrease) in Accounts Receivable
MAP PHARMACEUTICALS, INC. reported Increase (Decrease) in Accounts Receivable of $448.00 thousand for the 111-month period ending 2012-09-30, per its 10-Q filed 2012-11-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2012-11-06
- MAP PHARMACEUTICALS, INC. increase (decrease) in accounts receivable for the quarter ending 2012-09-30 was $219.00K.
- MAP PHARMACEUTICALS, INC. increase (decrease) in accounts receivable for the quarter ending 2012-06-30 was -$111.00K, a 135.35% decline year-over-year.
- MAP PHARMACEUTICALS, INC. increase (decrease) in accounts receivable for the quarter ending 2012-03-31 was -$296.00K, a 522.86% decline year-over-year.
- MAP PHARMACEUTICALS, INC. increase (decrease) in accounts receivable for the quarter ending 2011-12-31 was $396.00K.
- MAP PHARMACEUTICALS, INC. increase (decrease) in accounts receivable for fiscal 2011 was $636.00K.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month | Increase (Decrease) in Accounts Receivable 96 month | Increase (Decrease) in Accounts Receivable 99 month | Increase (Decrease) in Accounts Receivable 102 month | Increase (Decrease) in Accounts Receivable 105 month | Increase (Decrease) in Accounts Receivable 108 month | Increase (Decrease) in Accounts Receivable 111 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2012-09-30 | $219.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $108.00K derived: sum of 2 quarters · filed 2012-11-06 | -$188.00K 10-Q · filed 2012-11-06 | $208.00K derived: sum of 4 quarters · filed 2012-11-06 | $448.00K 10-Q · filed 2012-11-06 | |||||
| 2012-06-30 | -$111.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-27 | -$407.00K 10-Q · filed 2012-07-27 | -$11.00K derived: sum of 3 quarters · filed 2012-07-27 | -$155.00K derived: sum of 4 quarters · filed 2012-11-06 | $229.00K 10-Q · filed 2012-07-27 | |||||
| 2012-03-31 | -$296.00K 10-Q · filed 2012-05-08 | $100.00K derived: sum of 2 quarters · filed 2012-05-08 | -$44.00K derived: sum of 3 quarters · filed 2012-11-06 | $270.00K derived: sum of 4 quarters · filed 2012-11-06 | $340.00K 10-Q · filed 2012-05-08 | |||||
| 2011-12-31 | $396.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | $252.00K derived: sum of 2 quarters · filed 2012-11-06 | $566.00K derived: sum of 3 quarters · filed 2012-11-06 | $636.00K 10-K · filed 2012-03-30 | $636.00K 10-K · filed 2012-03-30 | |||||
| 2011-09-30 | -$144.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $170.00K derived: sum of 2 quarters · filed 2012-11-06 | $240.00K 10-Q · filed 2012-11-06 | $240.00K 10-Q/A · filed 2012-03-30 | ||||||
| 2011-06-30 | $314.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-27 | $384.00K 10-Q · filed 2012-07-27 | $384.00K 10-Q/A · filed 2012-03-30 | |||||||
| 2011-03-31 | $70.00K 10-Q · filed 2012-05-08 |